Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20340743 | 0.86 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL19725597 | 0.83 | CYP1A2 (0.47) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL2220947 | 0.81 | HSD17B10 (0.59) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL22473836 | 0.81 | HSD17B10 (0.59) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL10895591 | 0.81 | CYP1A2 (0.51) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL11579285 | 0.80 | HSD17B10 (0.39) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL17722807 | 0.79 | KCNJ11 (0.40) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL19725590 | 0.79 | HPGD (0.50) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL2127614 | 0.79 | ALDH1A1 (0.43) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 | |
| SCHEMBL27908454 | 0.79 | HSD17B10 (0.38) | CYP1A2CYP2D6CYP2C9HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160122269-A1 | COMPOUND CONTAINING PHENOLIC HYDROXYL GROUP, PHENOLIC RESIN, CURABLE COMPOSITION, CURED PRODUCT THEREOF, SEMICONDUCTOR SEALING MATERIAL, AND PRINTED CIRCUIT BOARD | DIC CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122269-A1 | COMPOUND CONTAINING PHENOLIC HYDROXYL GROUP, PHENOLIC RESIN, CURABLE COMPOSITION, CURED PRODUCT THEREOF, SEMICONDUCTOR SEALING MATERIAL, AND PRINTED CIRCUIT BOARD | ASH2L, SEM1, KDM1A | CYP1A2 924/4885CYP2D6 2938/4885CYP2C9 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.